CANNABIS POLAND AB ZY-10 (8TE) - Cash Flow Conversion Efficiency

Latest as of December 2025: -0.304x

Based on the latest financial reports, CANNABIS POLAND AB ZY-10 (8TE) has a cash flow conversion efficiency ratio of -0.304x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (€-463.42K ≈ $-541.78K USD) by net assets (€1.52 Million ≈ $1.78 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see CANNABIS POLAND AB ZY-10 stock valuation for the company's overall valuation and market capitalisation.

CANNABIS POLAND AB ZY-10 - Cash Flow Conversion Efficiency Trend (2021–2025)

This chart illustrates how CANNABIS POLAND AB ZY-10's cash flow conversion efficiency has evolved over time, based on yearly financial data.

CANNABIS POLAND AB ZY-10 Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of CANNABIS POLAND AB ZY-10 ranked by their cash flow conversion efficiency. See 8TE cash flow to debt ratio to evaluate how effectively operating cash flow covers total debt obligations.

Company Cash Flow Conversion Efficiency
Gujarat Lease Financing Limited
NSE:GLFL
0.049x
Scheerders van Kerchove's Verenigde fabrieken nv
BR:SCHD
0.091x
INVO Fertility, Inc.
NASDAQ:IVF
-0.304x
Heritage Distilling Holding Company, Inc.
NASDAQ:IPST
-0.076x
WINDFALL GEOTEK
F:L7C2
0.592x
Astron Paper & Board Mill Limited
NSE:ASTRON
0.079x
Ion Energy Ltd
V:ION
-0.208x
Eco Oro Minerals Corp
F:GQQ
0.056x

Annual Cash Flow Conversion Efficiency for CANNABIS POLAND AB ZY-10 (2021–2025)

The table below shows the annual cash flow conversion efficiency of CANNABIS POLAND AB ZY-10 from 2021 to 2025. View CANNABIS POLAND AB ZY-10 share price for real-time trading data and today's change.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 €1.52 Million
≈ $1.78 Million
€-2.17 Million
≈ $-2.54 Million
-1.426x -138.71%
2024-12-31 €3.54 Million
≈ $4.14 Million
€-2.11 Million
≈ $-2.47 Million
-0.598x +37.85%
2023-12-31 €1.36 Million
≈ $1.58 Million
€-1.30 Million
≈ $-1.52 Million
-0.961x +13.37%
2022-12-31 €321.96K
≈ $376.41K
€-357.28K
≈ $-417.70K
-1.110x +42.68%
2021-12-31 €480.84K
≈ $562.15K
€-930.97K
≈ $-1.09 Million
-1.936x --

About CANNABIS POLAND AB ZY-10

F:8TE Germany Drug Manufacturers - Specialty & Generic
Market Cap
$2.06 Million
€1.76 Million EUR
Market Cap Rank
#30379 Global
#2647 in Germany
Share Price
€0.03
Change (1 day)
-1.67%
52-Week Range
€0.02 - €0.05
All Time High
€0.69
About

Cannabis Poland S.A. operates in the medical cannabis industry in Poland. The company distributes and sells cannabidiol (CBD) oils and herbs, inhalers, and vaporizers, as well as dietary supplements and cosmetics for humans and animals. It sells its products through HempWish.pl and Vapem.eu online stores. The company also engages in the research and development of CBD-based drugs based on scienti… Read more